Acorn Regulatory NewsBrexitIndustry NewsJanet FitzgeraldMarketing Authorisation HoldersPharmaceutical
Watch The Northern Ireland Protocol Webinar
Acorn Regulatory hosted a webinar in association with TOPRA on March 4th, 2021 to look at the issue of the Northern Ireland Protocol from a consultancy standpoint. The webinar was a fully booked event and generated significant interest among regulatory...
Acorn Regulatory to Present TOPRA Webinar on Northern Ireland Protocol
Janet Fitzgerald, Regulatory Project Manager at Acorn Regulatory, will present on the consultancy approach to the Northern Ireland Protocol in a TOPRA webinar on March 4th at 1.00 pm. The presentation will focus on experiences dealing with the impact of...
Download Our Northern Ireland Protocol Pharmaceutical Guide
How will the Northern Ireland Protocol impact companies in the pharmaceutical sector? That is a question that we have been asked many times in recent months. The issue of the Northern Ireland Protocol has continued to be a source of...
The Northern Ireland Protocol & Medical Devices: Explained
How will the Northern Ireland Protocol impact companies in the medical devices sector? That is a question that we have been asked many times in recent months. Now, as the UK’s departure from the EU gets closer, we have created...
Most Read Brexit Articles of 2020
Acorn Regulatory has led the way in providing information and assistance to industry professionals since 2016. We have compiled some of the most read and useful articles in one place to help you to better understand how Brexit will impact...
How Will The Northern Ireland Protocol Impact Medical Device Companies?
Our clients have been contacting us in recent weeks with questions relating to the Northern Ireland Protocol and medical devices. They are eager to understand the intricacies of the Northern Ireland Protocol and how it will impact their companies. We...
How Will The Northern Ireland Protocol Impact Pharma Companies?
How will the Northern Ireland Protocol impact companies in the pharmaceutical sector? That is a question that we have been asked many times in recent months. The issue of the Northern Ireland Protocol has continued to be a source of...
Download ‘Regulatory Intelligence 9’ from Acorn Regulatory
‘Regulatory Intelligence 9’ from Acorn Regulatory has a wide range of articles covering issues such as Brexit, the new Medical Device Regulations, DCP Close Outs, and more. The articles in ‘Regulatory Intelligence 9’ have been written by members of our...
The Acorn Regulatory Brexit Guide No. 1 Revised for 2020
We published our first Brexit guide in July 2016. Back then, we looked at the potential implications for the life sciences sector. Now, we know much more about how Brexit will look at the moves that companies need to take...
Preparing for a No Deal Brexit – The 9th Acorn Regulatory Whitepaper
The seemingly never-ending Brexit negotiations have continued throughout the pandemic. Talks initially held virtually, have now progressed to face to face meetings. While the format of the meetings might have changed there has been little progress to report as both...
By using this website, you agree to our
cookie policy.
Close